MiMedx Price To Sales Ratio from 2010 to 2024
MDXG Stock | USD 6.27 0.02 0.32% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 3.17804463 | Current Value 3.02 | Quarterly Volatility 25.05042716 |
Check MiMedx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MiMedx main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.6 M, Interest Expense of 6.8 M or Selling General Administrative of 123.2 M, as well as many exotic indicators such as Price To Sales Ratio of 3.02, Dividend Yield of 0.0 or PTB Ratio of 6.8. MiMedx financial statements analysis is a perfect complement when working with MiMedx Valuation or Volatility modules.
MiMedx | Price To Sales Ratio |
Latest MiMedx's Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of MiMedx Group over the last few years. Price to Sales Ratio is figured by comparing MiMedx Group stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on MiMedx sales, a figure that is much harder to manipulate than other MiMedx Group multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period. MiMedx's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MiMedx's overall financial position and show how it may be relating to other accounts over time.
View | Last Reported 2.94 X | 10 Years Trend |
|
Price To Sales Ratio |
Timeline |
MiMedx Price To Sales Ratio Regression Statistics
Arithmetic Mean | 11.90 | |
Geometric Mean | 4.95 | |
Coefficient Of Variation | 210.58 | |
Mean Deviation | 12.22 | |
Median | 3.96 | |
Standard Deviation | 25.05 | |
Sample Variance | 627.52 | |
Range | 101 | |
R-Value | (0.55) | |
Mean Square Error | 473.68 | |
R-Squared | 0.30 | |
Significance | 0.03 | |
Slope | (3.06) | |
Total Sum of Squares | 8,785 |
MiMedx Price To Sales Ratio History
About MiMedx Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include MiMedx income statement, its balance sheet, and the statement of cash flows. MiMedx investors use historical funamental indicators, such as MiMedx's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although MiMedx investors may use each financial statement separately, they are all related. The changes in MiMedx's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on MiMedx's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on MiMedx Financial Statements. Understanding these patterns can help to make the right decision on long term investment in MiMedx. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Price To Sales Ratio | 3.18 | 3.02 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards MiMedx in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, MiMedx's short interest history, or implied volatility extrapolated from MiMedx options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of MiMedx Correlation against competitors. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for MiMedx Stock analysis
When running MiMedx's price analysis, check to measure MiMedx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MiMedx is operating at the current time. Most of MiMedx's value examination focuses on studying past and present price action to predict the probability of MiMedx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MiMedx's price. Additionally, you may evaluate how the addition of MiMedx to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
Is MiMedx's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MiMedx. If investors know MiMedx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MiMedx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 4 | Earnings Share 0.43 | Revenue Per Share 2.76 | Quarterly Revenue Growth 0.167 | Return On Assets 0.113 |
The market value of MiMedx Group is measured differently than its book value, which is the value of MiMedx that is recorded on the company's balance sheet. Investors also form their own opinion of MiMedx's value that differs from its market value or its book value, called intrinsic value, which is MiMedx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MiMedx's market value can be influenced by many factors that don't directly affect MiMedx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MiMedx's value and its price as these two are different measures arrived at by different means. Investors typically determine if MiMedx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MiMedx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.